UNDERSTANDING TYPE 5 DIABETES AND ITS LINK TO CHRONIC MALNUTRITION

Medically Reviewed by Dr. Sony Sherpa (MBBS)

Diabetes mellitus, a chronic metabolic disorder, has become one of the most significant public health issues of the 21st century. The 2025 edition of the IDF Diabetes Atlas estimates that 1 in 9 adults worldwide between 20 and 79 years of age are living with diabetes, and more than 40% remain undiagnosed.

Traditionally, diabetes has been categorized primarily into Type 1 and Type 2, each with distinct causes, pathophysiology, and treatment approaches. However, recent diabetes news and research have highlighted the existence of other types that fall outside the classic dichotomy. One such emerging type is Type 5 Diabetes, also known as Malnutrition-Related Diabetes Mellitus (MRDM).

The recognition of this condition represents a paradigm shift in how diabetes is classified and treated, especially in socioeconomically challenged regions. Initially observed in malnourished populations in the mid-20th century, particularly in tropical and subtropical regions, this form of diabetes presented with unique features that did not align neatly with Type 1 or Type 2 profiles.

Despite these observations, MRDM remained a marginal concept until the International Diabetes Federation (IDF) formally recognized Type 5 Diabetes in 2025, validating decades of clinical observations and urging the global health community to reevaluate the classification and management of diabetes in undernourished populations.

Overview of Diabetes Types

To understand Type 5 Diabetes, it is essential to contextualize it within the broader framework of diabetes classifications:

• Type 1 Diabetes is marked by the autoimmune destruction of pancreatic beta cells, with resultant absolute insulin deficiency.
• Type 2 Diabetes is strongly correlated to lifestyle factors and obesity, typically involving a combination of insulin resistance and relative insulin deficiency.
• Other forms include gestational diabetes and monogenic diabetes, each with specific genetic or physiological underpinnings.

What is Type 5 Diabetes?

Type 5 Diabetes, or Malnutrition-Related Diabetes Mellitus, is a unique form of diabetes that develops in individuals with a history of chronic undernutrition, often beginning in childhood or adolescence. Unlike Type 1 diabetes, which is autoimmune in nature, or Type 2 diabetes, which is driven by insulin resistance, Type 5 diabetes primarily involves severe insulin deficiency without autoimmune destruction of the pancreas and falls under the classification of Severe Insulin-Deficient Diabetes (SIDD).

The underlying mechanisms are complex and multifactorial, involving:

• Pancreatic damage due to chronic nutritional deficiency.
• Impaired development of beta cells.
• Possible alterations in exocrine pancreatic function (its role in digestion), which may affect insulin secretion.
• Endocrine adaptations in response to prolonged malnutrition that eventually become maladaptive.

Comparing Type 1 vs Type 2 vs Type 5 Diabetes

Common Symptoms and Age of Onset

The symptoms of Type 5 diabetes can resemble those of Type 1 and Type 2 and may include:

• Excessive thirst (polydipsia)
• Frequent urination (polyuria)
• Weight loss
• Fatigue
• Poor wound healing

The age of onset is usually during late adolescence or early adulthood, although the metabolic disturbances start much earlier due to long-standing undernutrition.

Causes and Risk Factors

1. Chronic Malnutrition

Type 5 diabetes is primarily attributable to malnutrition and undernutrition, particularly protein-energy malnutrition during critical periods of growth. As touched upon above, prolonged undernutrition impairs both the structural and functional development of the pancreas, especially its insulin-producing beta cells.

2. Pancreatic Damage

Chronic nutritional deprivation can lead to pancreatic calcification and fibrosis, reducing its capacity to produce insulin effectively. This condition has been identified in several tropical countries and has been historically referred to as tropical pancreatitis or fibrocalculous pancreatic diabetes (FCPD) - a subtype under the broader MRDM category.

3. Insulin Resistance vs. Insulin Deficiency

Unlike Type 2 diabetes, which is driven by insulin resistance, Type 5 diabetes primarily involves insulin deficiency. However, malnutrition may sometimes cause transient insulin resistance due to altered hormonal profiles, stress responses, or infections. Thus, distinguishing between insulin resistance and insulin deficiency as the underlying cause of diabetes is critical in diagnosing and managing this condition correctly.

4. Absence of Ketosis

A peculiar feature of Type 5 diabetes is the absence of ketosis, even in states of extreme insulin deficiency. This distinguishes it from Type 1 diabetes, where ketoacidosis is a common and dangerous complication.

Diagnosis

Diagnosing Type 5 diabetes presents a significant clinical challenge due to symptom overlap with Types 1 and 2. Misdiagnosis is common and can lead to inappropriate treatments.

Key Diagnostic Indicators Include:

• Low BMI or evidence of undernutrition
• Absence of autoimmune markers (e.g., GAD antibodies)
• Lack of family history of Type 2 diabetes
• Absence of ketoacidosis
• Poor response to oral hypoglycemics
• Imaging showing pancreatic calcification in some cases

Misdiagnosis can result in the application of standard insulin regimens, which may lead to hypoglycemia or poor glycemic control due to an unaddressed nutritional component. Essentially, the public health implications of misclassifying diabetes types can be profound, potentially leading to systematic under-treatment, over-medication, and wasted resources.

Treatment and Management

Managing Type 5 diabetes requires a multifaceted approach that addresses both the metabolic and nutritional dimensions of the disease.

1. Nutritional Rehabilitation

The cornerstone of therapy is nutritional rehabilitation, including:

• Adequate caloric intake
• High-quality protein supplementation
• Micronutrient support (zinc, vitamin D, magnesium)
• Addressing underlying malabsorptive issues

This not only improves overall health but may also partially restore pancreatic function and insulin sensitivity.

2. Medication

While insulin is often necessary due to the insulin-deficient nature of the disease, the response can vary. Small doses of insulin may be used to prevent complications without causing hypoglycemia.

Oral hypoglycemics, such as metformin, are often ineffective alone but may be used in combination with insulin in some cases.

3. Avoiding Mismanagement

One of the greatest dangers is inappropriate treatment, such as administering high doses of insulin (appropriate for Type 1 diabetes) in individuals with poor nutritional status. This can lead to severe hypoglycemia, increased morbidity, and even fatality.

Prognosis

The prognosis of Type 5 diabetes varies based on the timeliness and accuracy of diagnosis and the comprehensiveness of the treatment. In the absence of proper nutritional and medical intervention, this condition can lead to:

• Severe complications (e.g., blindness, kidney failure)
• Infections
• Reduced life expectancy

When treated appropriately, patients can achieve good glycemic control and lead relatively normal lives. However, delays in diagnosis or inadequate nutritional support are associated with high fatality rates, especially in resource-limited settings.

Global Health Implications and Latest Research

Prevalence and Affected Populations

Type 5 diabetes predominantly affects populations in:

• Sub-Saharan Africa
• South Asia
• Southeast Asia
• Parts of Latin America

Food insecurity, poverty, and lack of healthcare access, which are prevalent in these regions, are major drivers of both undernutrition and delayed diagnosis.

IDF Initiatives

The International Diabetes Federation has initiated several actions to address this challenge:

• Updated classification frameworks including Type 5 Diabetes
• Training programs for healthcare workers in affected regions
• Public awareness campaigns emphasizing the link between malnutrition and diabetes

Further Research and Steps Forward

The recognition of MRDM as Type 5 Diabetes opens several avenues for research:

• Development of diagnostic criteria and biomarkers to differentiate MRDM from other types early.
• Clinical trials to optimize insulin dosing strategies specific to MRDM patients.
• Nutritional interventions tailored to socioeconomically disadvantaged communities.
• Integration of community health programs to identify and treat at-risk children before diabetes develops.

Conclusion

The formal recognition of Type 5 Diabetes by the IDF marks a turning point in global diabetes care. Malnutrition-Related Diabetes Mellitus is not just a medical issue - it is a socio-economic and developmental problem that affects some of the world’s most vulnerable populations.

Understanding the unique pathophysiology, diagnostic challenges, and management needs of MRDM is essential for healthcare professionals, researchers, and policymakers alike. Addressing this condition requires not only medical treatment but also socio-economic upliftment, food security, and public health investment. As awareness grows, so too must our commitment to ensuring that no individual is left behind in the fight against diabetes - no matter where they live or what they have on their plate.

To search for the best Endocrinology Healthcare Providers in Germany, India, Malaysia, Spain, Thailand, the UAE, UK, the USA, please use the Mya Care search engine.

To search for the best healthcare providers worldwide, please use the Mya Care search engine.

References:

Show All ▼

 

Disclaimer